Literature DB >> 15753930

Dosimetric benefits of respiratory gating: a preliminary study.

Laura E Butler1, Kenneth M Forster, Craig W Stevens, Charles Bloch, H Helen Liu, Susan L Tucker, Ritsuko Komaki, Zhongxing Liao, George Starkschall.   

Abstract

In this study, we compared the amount of lung tissue irradiated when respiratory gating was imposed during expiration with the amount of lung tissue irradiated when gating was imposed during inspiration. Our hypothesis was that the amount of lung tissue spared increased as inspiration increased. Computed tomography (CT) image data sets were acquired for 10 patients who had been diagnosed with primary bronchogenic carcinoma. Data sets were acquired during free breathing and during breath-holds at 0% tidal volume and 100% tidal volume, and, when possible, at deep inspiration, corresponding to approximately 60% vital capacity. Two treatment plans were developed on the basis of each of the gated data sets: one in which the treatment portals were those of the free-breathing plan, and the other in which the treatment portals were based on the gated planning target volumes. Dose-mass histograms of the lungs calculated at 0% tidal volume were compared to those calculated at deep inspiration and at 100% tidal volume. Data extracted from the dose-mass histograms were used to determine the most dosimetrically beneficial point to gate, the reduction in the amount of irradiated lung tissue that resulted from gating, and any disease characteristics that might predict a greater need for gating. The data showed a reduction in the mass of normal tissue irradiated when treatment portals based on the gated planning target volume were used. More normal lung tissue was spared at deep inspiration than at the other two gating points for all patients, but normal lung tissue was spared at every point in the respiratory cycle. No significant differences in the amount of irradiated tissue by disease characteristic were identified. Respiratory gating of thoracic radiation treatments can often improve the quality of the treatment plan, but it may not be possible to determine which patients may benefit from gating prior to performing the actual treatment planning.

Entities:  

Mesh:

Year:  2004        PMID: 15753930     DOI: 10.1120/jacmp.26.146

Source DB:  PubMed          Journal:  J Appl Clin Med Phys        ISSN: 1526-9914            Impact factor:   2.102


  11 in total

1.  Dose-mass inverse optimization for minimally moving thoracic lesions.

Authors:  I B Mihaylov; E G Moros
Journal:  Phys Med Biol       Date:  2015-04-24       Impact factor: 3.609

2.  Dynamic gating window for compensation of baseline shift in respiratory-gated radiation therapy.

Authors:  Eric W Pepin; Huanmei Wu; Hiroki Shirato
Journal:  Med Phys       Date:  2011-04       Impact factor: 4.071

3.  Quantitative assessment of irradiated lung volume and lung mass in breast cancer patients treated with tangential fields in combination with deep inspiration breath hold (DIBH).

Authors:  Brigitte Zurl; Heidi Stranzl; Peter Winkler; Karin Sigrid Kapp
Journal:  Strahlenther Onkol       Date:  2010-02-22       Impact factor: 3.621

4.  Respiratory gating during stereotactic body radiotherapy for lung cancer reduces tumor position variability.

Authors:  Tetsuo Saito; Tomohiko Matsuyama; Ryo Toya; Yoshiyuki Fukugawa; Takamasa Toyofuku; Akiko Semba; Natsuo Oya
Journal:  PLoS One       Date:  2014-11-07       Impact factor: 3.240

Review 5.  Mathematical Formulation of DMH-Based Inverse Optimization.

Authors:  Ivaylo B Mihaylov; Eduardo G Moros
Journal:  Front Oncol       Date:  2014-11-17       Impact factor: 6.244

6.  Automated inverse optimization facilitates lower doses to normal tissue in pancreatic stereotactic body radiotherapy.

Authors:  Ivaylo B Mihaylov; Eric A Mellon; Raphael Yechieli; Lorraine Portelance
Journal:  PLoS One       Date:  2018-01-19       Impact factor: 3.240

7.  Monitoring deep inspiration breath hold for left-sided localized breast cancer radiotherapy with an in-house developed laser distance meter system.

Authors:  Christer A Jensen; Tatiana Abramova; Jomar Frengen; Jo-Åsmund Lund
Journal:  J Appl Clin Med Phys       Date:  2017-07-29       Impact factor: 2.102

8.  Quality assurance evaluation of delivery of respiratory-gated treatments.

Authors:  Alex Cardenas; Jonas Fontenot; Kenneth M Forster; Craig W Stevens; George Starkschall
Journal:  J Appl Clin Med Phys       Date:  2004-07-01       Impact factor: 2.102

9.  Comparison of breath-hold and free-breathing positions of an external fiducial by analysis of respiratory traces.

Authors:  Sandeep Hunjan; George Starkschall; Isaac Rosen; Karl Prado; Naresh Tolani; Peter Balter
Journal:  J Appl Clin Med Phys       Date:  2008-06-23       Impact factor: 2.102

10.  Evaluation of the combined use of two different respiratory monitoring systems for 4D CT simulation and gated treatment.

Authors:  Jie Liu; Teh Lin; Jiajin Fan; Lili Chen; Robert Price; C-M Charlie Ma
Journal:  J Appl Clin Med Phys       Date:  2018-08-13       Impact factor: 2.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.